Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae</i> in Critically Ill Patients

Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae</i> in Critically Ill Patients

<b>: </b>We aimed to evaluate tigecycline on the clinical effectiveness in treating complicated skin and soft tissue infections (cSSTI), complicated intra-abdominal infections (cIAI), and pneumonia, caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, as data are...

Full description

Bibliographic Details
Main Authors: Wen-Liang Yu, Nan-Yao Lee, Jann-Tay Wang, Wen-Chien Ko, Chung-Han Ho, Yin-Ching Chuang
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Antibiotics
Subjects:
Enterobacteriaceae
ESBL
carbapenem resistance
SOFA score
tigecycline
Online Access:https://www.mdpi.com/2079-6382/9/5/231

Internet

https://www.mdpi.com/2079-6382/9/5/231

Similar Items